Insider · CIK 0001809204

Cummings Keith Lamont

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001809204

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−113K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−76K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+76K sh	—	—	76,047
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−18.2K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+18.2K sh	—	—	18,198
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−74.3K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+74.3K sh	—	—	74,250
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−124K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+124K sh	—	—	124,000
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+111K sh	—	—	110,500
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+113K sh	—	—	113,300
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−76.2K sh	—	—	0
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+76.2K sh	—	—	76,200
2026-04-17	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−111K sh	—	—	0
2026-01-22	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+400K sh	—	—	400,000
2026-01-20	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−24K sh	$1.28	−$30.7K	297,214
2025-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+56.7K sh	—	—	319,258
2025-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+113K sh	—	—	113,300
2025-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−20.1K sh	$11.20	−$226K	262,608
2024-07-10	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−10.9K sh	$11.56	−$126K	282,115
2024-07-09	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+21.3K sh	—	—	293,026
2024-05-02	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−21K sh	—	—	76,047
2024-05-02	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+21K sh	$2.08	+$43.7K	271,713
2024-01-23	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+55.3K sh	—	—	249,855
2024-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+111K sh	—	—	110,500
2024-01-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−9,781 sh	$17.23	−$169K	194,605
2023-07-17	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−19.8K sh	$18.01	−$356K	203,999
2023-07-14	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+38.8K sh	—	—	223,770
2023-06-13	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−30.8K sh	—	—	97,047
2023-06-13	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+30.8K sh	$2.08	+$64K	185,020
2023-06-09	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,800 sh	—	—	127,797
2023-06-09	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,800 sh	$2.08	+$12.1K	154,270
2023-03-30	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−9,960 sh	$26.52	−$264K	148,470
2023-03-29	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+19.4K sh	—	—	158,430
2023-01-25	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+54K sh	—	—	138,424
2023-01-25	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+76.2K sh	—	—	76,200
2023-01-23	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−30K sh	$35.00	−$1.05M	84,424
2023-01-23	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+12.5K sh	$2.08	+$26K	96,924
2023-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.5K sh	—	—	18,198
2023-01-23	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−12.5K sh	—	—	133,597
2023-01-23	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.5K sh	$6.22	+$109K	114,424
2022-12-22	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,000 sh	$2.08	+$8,320	84,424
2022-12-22	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,000 sh	—	—	146,097
2022-12-20	PLRXPLIANT THERAPEUTICS, INC.S Sale	Chief Financial Officer	SSale	−9,643 sh	$19.10	−$184K	80,424
2022-12-19	PLRXPLIANT THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+19.4K sh	—	—	90,067
2022-01-26	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+124K sh	—	—	124,000
2021-09-03	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	150,097
2021-09-03	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	$2.08	+$41.6K	67,621
2021-03-05	PLRXPLIANT THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	170,097
2021-03-05	PLRXPLIANT THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+20K sh	$2.08	+$41.6K	47,621

Recent filings

Accepted (ET)
Apr 174
Cummings Keith Lamont0001746473-26-000054
SEC(opens sec.gov)
Jan 264
Cummings Keith Lamont0001746473-26-000020
SEC(opens sec.gov)
Jan 224
Cummings Keith Lamont0001746473-26-000012
SEC(opens sec.gov)
Jan 274
Cummings Keith Lamont0001746473-25-000011
SEC(opens sec.gov)
Jan 224
Cummings Keith Lamont0001746473-25-000005
SEC(opens sec.gov)
Jul 124
Cummings Keith Lamont0001746473-24-000125
SEC(opens sec.gov)

Companies

PLIANT THERAPEUTICS, INC.Chief Financial OfficerPLRX

Address

C/O PLIANT THERAPEUTICS, INC. 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080